Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review
• Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM....
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Heppt, Markus V. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2017 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
9 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Using regression analysis to predict the future energy consumption of a supermarket in the UK - Braun, M.R. ELSEVIER, 2014, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:60 ; year:2017 ; pages:44-52 ; extent:9 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ctrv.2017.08.009 |
|---|
| Katalog-ID: |
ELV040840735 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV040840735 | ||
| 003 | DE-627 | ||
| 005 | 20230624080428.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180725s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ctrv.2017.08.009 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000019.pica |
| 035 | |a (DE-627)ELV040840735 | ||
| 035 | |a (ELSEVIER)S0305-7372(17)30132-9 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 620 |q VZ |
| 082 | 0 | 4 | |a 150 |a 300 |q VZ |
| 084 | |a 77.52 |2 bkl | ||
| 100 | 1 | |a Heppt, Markus V. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review |
| 264 | 1 | |c 2017 | |
| 300 | |a 9 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM. | ||
| 650 | 7 | |a Pembrolizumab |2 Elsevier | |
| 650 | 7 | |a Immune checkpoint blockade |2 Elsevier | |
| 650 | 7 | |a Ipilimumab |2 Elsevier | |
| 650 | 7 | |a Nivolumab |2 Elsevier | |
| 650 | 7 | |a Uveal melanoma |2 Elsevier | |
| 650 | 7 | |a CTLA-4 |2 Elsevier | |
| 700 | 1 | |a Steeb, Theresa |4 oth | |
| 700 | 1 | |a Schlager, Justin Gabriel |4 oth | |
| 700 | 1 | |a Rosumeck, Stefanie |4 oth | |
| 700 | 1 | |a Dressler, Corinna |4 oth | |
| 700 | 1 | |a Ruzicka, Thomas |4 oth | |
| 700 | 1 | |a Nast, Alexander |4 oth | |
| 700 | 1 | |a Berking, Carola |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Braun, M.R. ELSEVIER |t Using regression analysis to predict the future energy consumption of a supermarket in the UK |d 2014 |g Amsterdam [u.a.] |w (DE-627)ELV01225004X |
| 773 | 1 | 8 | |g volume:60 |g year:2017 |g pages:44-52 |g extent:9 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ctrv.2017.08.009 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 77.52 |j Differentielle Psychologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 60 |j 2017 |h 44-52 |g 9 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m v h mv mvh |
|---|---|
| matchkey_str |
hepptmarkusvsteebtheresaschlagerjustinga:2017----:muehcpitlcaeourscalomtsaiuelea |
| hierarchy_sort_str |
2017 |
| bklnumber |
77.52 |
| publishDate |
2017 |
| allfields |
10.1016/j.ctrv.2017.08.009 doi GBV00000000000019.pica (DE-627)ELV040840735 (ELSEVIER)S0305-7372(17)30132-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 620 VZ 150 300 VZ 77.52 bkl Heppt, Markus V. verfasserin aut Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review 2017 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM. Pembrolizumab Elsevier Immune checkpoint blockade Elsevier Ipilimumab Elsevier Nivolumab Elsevier Uveal melanoma Elsevier CTLA-4 Elsevier Steeb, Theresa oth Schlager, Justin Gabriel oth Rosumeck, Stefanie oth Dressler, Corinna oth Ruzicka, Thomas oth Nast, Alexander oth Berking, Carola oth Enthalten in Elsevier Braun, M.R. ELSEVIER Using regression analysis to predict the future energy consumption of a supermarket in the UK 2014 Amsterdam [u.a.] (DE-627)ELV01225004X volume:60 year:2017 pages:44-52 extent:9 https://doi.org/10.1016/j.ctrv.2017.08.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 77.52 Differentielle Psychologie VZ AR 60 2017 44-52 9 045F 610 |
| spelling |
10.1016/j.ctrv.2017.08.009 doi GBV00000000000019.pica (DE-627)ELV040840735 (ELSEVIER)S0305-7372(17)30132-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 620 VZ 150 300 VZ 77.52 bkl Heppt, Markus V. verfasserin aut Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review 2017 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM. Pembrolizumab Elsevier Immune checkpoint blockade Elsevier Ipilimumab Elsevier Nivolumab Elsevier Uveal melanoma Elsevier CTLA-4 Elsevier Steeb, Theresa oth Schlager, Justin Gabriel oth Rosumeck, Stefanie oth Dressler, Corinna oth Ruzicka, Thomas oth Nast, Alexander oth Berking, Carola oth Enthalten in Elsevier Braun, M.R. ELSEVIER Using regression analysis to predict the future energy consumption of a supermarket in the UK 2014 Amsterdam [u.a.] (DE-627)ELV01225004X volume:60 year:2017 pages:44-52 extent:9 https://doi.org/10.1016/j.ctrv.2017.08.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 77.52 Differentielle Psychologie VZ AR 60 2017 44-52 9 045F 610 |
| allfields_unstemmed |
10.1016/j.ctrv.2017.08.009 doi GBV00000000000019.pica (DE-627)ELV040840735 (ELSEVIER)S0305-7372(17)30132-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 620 VZ 150 300 VZ 77.52 bkl Heppt, Markus V. verfasserin aut Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review 2017 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM. Pembrolizumab Elsevier Immune checkpoint blockade Elsevier Ipilimumab Elsevier Nivolumab Elsevier Uveal melanoma Elsevier CTLA-4 Elsevier Steeb, Theresa oth Schlager, Justin Gabriel oth Rosumeck, Stefanie oth Dressler, Corinna oth Ruzicka, Thomas oth Nast, Alexander oth Berking, Carola oth Enthalten in Elsevier Braun, M.R. ELSEVIER Using regression analysis to predict the future energy consumption of a supermarket in the UK 2014 Amsterdam [u.a.] (DE-627)ELV01225004X volume:60 year:2017 pages:44-52 extent:9 https://doi.org/10.1016/j.ctrv.2017.08.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 77.52 Differentielle Psychologie VZ AR 60 2017 44-52 9 045F 610 |
| allfieldsGer |
10.1016/j.ctrv.2017.08.009 doi GBV00000000000019.pica (DE-627)ELV040840735 (ELSEVIER)S0305-7372(17)30132-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 620 VZ 150 300 VZ 77.52 bkl Heppt, Markus V. verfasserin aut Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review 2017 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM. Pembrolizumab Elsevier Immune checkpoint blockade Elsevier Ipilimumab Elsevier Nivolumab Elsevier Uveal melanoma Elsevier CTLA-4 Elsevier Steeb, Theresa oth Schlager, Justin Gabriel oth Rosumeck, Stefanie oth Dressler, Corinna oth Ruzicka, Thomas oth Nast, Alexander oth Berking, Carola oth Enthalten in Elsevier Braun, M.R. ELSEVIER Using regression analysis to predict the future energy consumption of a supermarket in the UK 2014 Amsterdam [u.a.] (DE-627)ELV01225004X volume:60 year:2017 pages:44-52 extent:9 https://doi.org/10.1016/j.ctrv.2017.08.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 77.52 Differentielle Psychologie VZ AR 60 2017 44-52 9 045F 610 |
| allfieldsSound |
10.1016/j.ctrv.2017.08.009 doi GBV00000000000019.pica (DE-627)ELV040840735 (ELSEVIER)S0305-7372(17)30132-9 DE-627 ger DE-627 rakwb eng 610 610 DE-600 620 VZ 150 300 VZ 77.52 bkl Heppt, Markus V. verfasserin aut Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review 2017 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM. Pembrolizumab Elsevier Immune checkpoint blockade Elsevier Ipilimumab Elsevier Nivolumab Elsevier Uveal melanoma Elsevier CTLA-4 Elsevier Steeb, Theresa oth Schlager, Justin Gabriel oth Rosumeck, Stefanie oth Dressler, Corinna oth Ruzicka, Thomas oth Nast, Alexander oth Berking, Carola oth Enthalten in Elsevier Braun, M.R. ELSEVIER Using regression analysis to predict the future energy consumption of a supermarket in the UK 2014 Amsterdam [u.a.] (DE-627)ELV01225004X volume:60 year:2017 pages:44-52 extent:9 https://doi.org/10.1016/j.ctrv.2017.08.009 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 77.52 Differentielle Psychologie VZ AR 60 2017 44-52 9 045F 610 |
| language |
English |
| source |
Enthalten in Using regression analysis to predict the future energy consumption of a supermarket in the UK Amsterdam [u.a.] volume:60 year:2017 pages:44-52 extent:9 |
| sourceStr |
Enthalten in Using regression analysis to predict the future energy consumption of a supermarket in the UK Amsterdam [u.a.] volume:60 year:2017 pages:44-52 extent:9 |
| format_phy_str_mv |
Article |
| bklname |
Differentielle Psychologie |
| institution |
findex.gbv.de |
| topic_facet |
Pembrolizumab Immune checkpoint blockade Ipilimumab Nivolumab Uveal melanoma CTLA-4 |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
Using regression analysis to predict the future energy consumption of a supermarket in the UK |
| authorswithroles_txt_mv |
Heppt, Markus V. @@aut@@ Steeb, Theresa @@oth@@ Schlager, Justin Gabriel @@oth@@ Rosumeck, Stefanie @@oth@@ Dressler, Corinna @@oth@@ Ruzicka, Thomas @@oth@@ Nast, Alexander @@oth@@ Berking, Carola @@oth@@ |
| publishDateDaySort_date |
2017-01-01T00:00:00Z |
| hierarchy_top_id |
ELV01225004X |
| dewey-sort |
3610 |
| id |
ELV040840735 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV040840735</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624080428.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180725s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ctrv.2017.08.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000019.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV040840735</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0305-7372(17)30132-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">620</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="a">300</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Heppt, Markus V.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pembrolizumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immune checkpoint blockade</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ipilimumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nivolumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Uveal melanoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CTLA-4</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steeb, Theresa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schlager, Justin Gabriel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rosumeck, Stefanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dressler, Corinna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ruzicka, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nast, Alexander</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berking, Carola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Braun, M.R. ELSEVIER</subfield><subfield code="t">Using regression analysis to predict the future energy consumption of a supermarket in the UK</subfield><subfield code="d">2014</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV01225004X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:60</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:44-52</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ctrv.2017.08.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.52</subfield><subfield code="j">Differentielle Psychologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">60</subfield><subfield code="j">2017</subfield><subfield code="h">44-52</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Heppt, Markus V. |
| spellingShingle |
Heppt, Markus V. ddc 610 ddc 620 ddc 150 bkl 77.52 Elsevier Pembrolizumab Elsevier Immune checkpoint blockade Elsevier Ipilimumab Elsevier Nivolumab Elsevier Uveal melanoma Elsevier CTLA-4 Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review |
| authorStr |
Heppt, Markus V. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV01225004X |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 620 - Engineering & allied operations 150 - Psychology 300 - Social sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 620 VZ 150 300 VZ 77.52 bkl Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review Pembrolizumab Elsevier Immune checkpoint blockade Elsevier Ipilimumab Elsevier Nivolumab Elsevier Uveal melanoma Elsevier CTLA-4 Elsevier |
| topic |
ddc 610 ddc 620 ddc 150 bkl 77.52 Elsevier Pembrolizumab Elsevier Immune checkpoint blockade Elsevier Ipilimumab Elsevier Nivolumab Elsevier Uveal melanoma Elsevier CTLA-4 |
| topic_unstemmed |
ddc 610 ddc 620 ddc 150 bkl 77.52 Elsevier Pembrolizumab Elsevier Immune checkpoint blockade Elsevier Ipilimumab Elsevier Nivolumab Elsevier Uveal melanoma Elsevier CTLA-4 |
| topic_browse |
ddc 610 ddc 620 ddc 150 bkl 77.52 Elsevier Pembrolizumab Elsevier Immune checkpoint blockade Elsevier Ipilimumab Elsevier Nivolumab Elsevier Uveal melanoma Elsevier CTLA-4 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
t s ts j g s jg jgs s r sr c d cd t r tr a n an c b cb |
| hierarchy_parent_title |
Using regression analysis to predict the future energy consumption of a supermarket in the UK |
| hierarchy_parent_id |
ELV01225004X |
| dewey-tens |
610 - Medicine & health 620 - Engineering 150 - Psychology 300 - Social sciences, sociology & anthropology |
| hierarchy_top_title |
Using regression analysis to predict the future energy consumption of a supermarket in the UK |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV01225004X |
| title |
Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review |
| ctrlnum |
(DE-627)ELV040840735 (ELSEVIER)S0305-7372(17)30132-9 |
| title_full |
Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review |
| author_sort |
Heppt, Markus V. |
| journal |
Using regression analysis to predict the future energy consumption of a supermarket in the UK |
| journalStr |
Using regression analysis to predict the future energy consumption of a supermarket in the UK |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 100 - Philosophy & psychology 300 - Social sciences |
| recordtype |
marc |
| publishDateSort |
2017 |
| contenttype_str_mv |
zzz |
| container_start_page |
44 |
| author_browse |
Heppt, Markus V. |
| container_volume |
60 |
| physical |
9 |
| class |
610 610 DE-600 620 VZ 150 300 VZ 77.52 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Heppt, Markus V. |
| doi_str_mv |
10.1016/j.ctrv.2017.08.009 |
| dewey-full |
610 620 150 300 |
| title_sort |
immune checkpoint blockade for unresectable or metastatic uveal melanoma: a systematic review |
| title_auth |
Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review |
| abstract |
• Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM. |
| abstractGer |
• Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM. |
| abstract_unstemmed |
• Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review |
| url |
https://doi.org/10.1016/j.ctrv.2017.08.009 |
| remote_bool |
true |
| author2 |
Steeb, Theresa Schlager, Justin Gabriel Rosumeck, Stefanie Dressler, Corinna Ruzicka, Thomas Nast, Alexander Berking, Carola |
| author2Str |
Steeb, Theresa Schlager, Justin Gabriel Rosumeck, Stefanie Dressler, Corinna Ruzicka, Thomas Nast, Alexander Berking, Carola |
| ppnlink |
ELV01225004X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ctrv.2017.08.009 |
| up_date |
2024-07-06T18:32:16.746Z |
| _version_ |
1803855579575222272 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV040840735</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624080428.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180725s2017 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ctrv.2017.08.009</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000019.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV040840735</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0305-7372(17)30132-9</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">620</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="a">300</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">77.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Heppt, Markus V.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Immune checkpoint blockade for unresectable or metastatic uveal melanoma: A systematic review</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2017</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Metastatic uveal melanoma (UM) is an orphan disease of high unmet need. • The current use of immune checkpoint blockade in UM is not evidence-based. • A systematic review on immune checkpoint blockade for UM was performed. • CTLA-4 blockade lacks efficacy but maintains toxicity in metastatic UM.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Pembrolizumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immune checkpoint blockade</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ipilimumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nivolumab</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Uveal melanoma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">CTLA-4</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Steeb, Theresa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schlager, Justin Gabriel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rosumeck, Stefanie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dressler, Corinna</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ruzicka, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nast, Alexander</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Berking, Carola</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Braun, M.R. ELSEVIER</subfield><subfield code="t">Using regression analysis to predict the future energy consumption of a supermarket in the UK</subfield><subfield code="d">2014</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV01225004X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:60</subfield><subfield code="g">year:2017</subfield><subfield code="g">pages:44-52</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ctrv.2017.08.009</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">77.52</subfield><subfield code="j">Differentielle Psychologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">60</subfield><subfield code="j">2017</subfield><subfield code="h">44-52</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.3988256 |